Clinical trial

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

NCT03250910

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-08-01

PhasePHASE4

Study timeline

Study start (actual)2016-08-01Date precision: day

Registry last updated2017-12-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C Virus Infection, Response to Therapy ofunresolved

Human Immunodeficiency Virusunresolved

Interventions

Sofosbuvir and VelpatasvirDRUG

RibavirinDRUG · verified · RxNorm: ribavirin

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03250910 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.